معرفی
James Brigaitis is an Adjunct Assistant Professor at the Leonard N. Stern School of Business, New York University, where he teaches courses on innovation in pharmaceuticals and biologics. With over 30 years of industry experience, he brings deep expertise in commercial strategy and market transformation in the biopharmaceutical sector.
His academic background includes:
- B.A. in Economics from Northwestern University
- M.B.A. in Marketing and Finance from the University of Chicago
His research and professional interests center on pharmaceutical innovation, strategic marketing of complex therapies, and commercial development in emerging biotech firms. His industry experience spans leadership roles in global marketing, including at Pfizer, and founding a specialized consulting firm.
While no peer-reviewed articles are listed in the provided text, his work reflects a strong focus on translating scientific innovation into market success, particularly in neuroscience, infectious diseases, and mental health therapeutics.
He has no listed scientific awards in the provided material.
James Brigaitis advises and consults for emerging biopharmaceutical companies, leveraging his experience in venture-backed startups and product launches. He has been instrumental in securing venture capital and commercializing novel therapies, such as the antibiotic Solosec. His teaching bridges academic theory with real-world industry practice.
There is no mention of formal research labs or collaborative teams in the provided text.
